{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:52:12Z","timestamp":1768701132379,"version":"3.49.0"},"reference-count":14,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"3941","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Science"],"published-print":{"date-parts":[[1970,7,10]]},"abstract":"<jats:p>Intravenous doses of amantadine hydrochloride, an antiviral drug, as small as 0.08 milligram per kilogram may release dopamine and other catecholamines from neuronal storage sites in dogs primed with dopamine. This release may account for the reported efficacy of amantadine hydrochloride in the treatment of human parkinsonism.<\/jats:p>","DOI":"10.1126\/science.169.3941.203","type":"journal-article","created":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T12:56:56Z","timestamp":1160053016000},"page":"203-204","source":"Crossref","is-referenced-by-count":133,"title":["Amantadine-Dopamine Interaction: Possible Mode of Action in Parkinsonism"],"prefix":"10.1126","volume":"169","author":[{"given":"R. P.","family":"Grelak","sequence":"first","affiliation":[{"name":"E. I. du Pont de Nemours and Co., Inc., Pharmaceuticals Division, Industrial and Biochemicals Department, Wilmington, Delaware"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Clark","sequence":"additional","affiliation":[{"name":"E. I. du Pont de Nemours and Co., Inc., Pharmaceuticals Division, Industrial and Biochemicals Department, Wilmington, Delaware"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Stump","sequence":"additional","affiliation":[{"name":"E. I. du Pont de Nemours and Co., Inc., Pharmaceuticals Division, Industrial and Biochemicals Department, Wilmington, Delaware"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. G.","family":"Vernier","sequence":"additional","affiliation":[{"name":"E. I. du Pont de Nemours and Co., Inc., Pharmaceuticals Division, Industrial and Biochemicals Department, Wilmington, Delaware"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"221","reference":[{"key":"e_1_2_1_1_1","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1126\/science.133.3465.1706.a","volume":"133","year":"1961","unstructured":"BARBEAU, A, SCIENCE 133: 1706 (1961).","journal-title":"SCIENCE"},{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.144.3620.862"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","volume":"38","year":"1960","unstructured":"EHRINGER, H, VERTEILUNG VON NORADRENALIN UND DOPAMIN (3-HYDROXYTYRAMIN) IM GEHIRN DES MENSCHEN UND IHR VERHALTEN BEI ERKRANKUNGEN DES EXTRAPYRAMIDALEN SYSTEMS, KLINISCHE WOCHENSCHRIFT 38: 1236 (1960).","journal-title":"KLINISCHE WOCHENSCHRIFT"},{"key":"e_1_2_1_4_1","first-page":"703","year":"1964","unstructured":"Jackson, G. G., Antimicrobial Agents and Chemotherapy: 703 (1964).","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"e_1_2_1_5_1","first-page":"805","volume":"29","year":"1968","unstructured":"KLAWANS, H.L., DISEASES OF THE NERVOUS SYSTEM 29: 805 (1968).","journal-title":"DISEASES OF THE NERVOUS SYSTEM"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3181\/00379727-129-33395","volume":"129","year":"1968","unstructured":"MCGAHEN, J.W., INFLUENZA INFECTIONS OF MICE .I. CURATIVE ACTIVITY OF AMANTADINE HCL, PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 129: 678 (1968).","journal-title":"PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE"},{"key":"e_1_2_1_7_1","first-page":"464","volume":"1","year":"1970","unstructured":"MILLAC, P, AMANTADINE IN PARKINSONS DISEASE, LANCET 1: 464 (1970).","journal-title":"LANCET"},{"key":"e_1_2_1_8_1","first-page":"259","volume":"1","year":"1970","unstructured":"PARKES, J.D., CONTROLLED TRIAL OF AMANTADINE HYDROCHLORIDE IN PARKINSONS DISEASE, LANCET 1: 259 (1970).","journal-title":"LANCET"},{"key":"e_1_2_1_9_1","unstructured":"PRICE W.A. PERSONAL COMMUNICATION."},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1476-5381.1947.tb00336.x","volume":"2","year":"1947","unstructured":"SCHILD, H.O., PA, A NEW SCALE FOR THE MEASUREMENT OF DRUG ANTAGONISM, BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY 2: 189 (1947).","journal-title":"BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/jama.1969.03160070046011","volume":"208","year":"1969","unstructured":"SCHWAB, R.S., AMANTADINE IN TREATMENT OF PARKINSONS DISEASE, JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 208: 1168 (1969).","journal-title":"JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/0041-008X(69)90066-0","volume":"15","year":"1969","unstructured":"VERNIER, V.G., TOXICOLOGIC AND PHARMACOLOGIC PROPERTIES OF AMANTADINE HYDROCHLORIDE, TOXICOLOGY AND APPLIED PHARMACOLOGY 15: 642 (1969).","journal-title":"TOXICOLOGY AND APPLIED PHARMACOLOGY"},{"key":"e_1_2_1_13_1","first-page":"325","volume":"68","year":"1969","unstructured":"WEETH, J.B., WISCONSIN MEDICAL JOURNAL 68: 325 (1969).","journal-title":"WISCONSIN MEDICAL JOURNAL"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJM196909112811102","volume":"281","year":"1969","unstructured":"WINGFIELD, W.L., THERAPEUTIC EFFICACY OF AMANTADINE HC1 AND RIMANTADINE HC1 IN NATURALLY OCCURRING INFLUENZA A2 RESPIRATORY ILLNESS IN MAN, NEW ENGLAND JOURNAL OF MEDICINE 281: 579 (1969).","journal-title":"NEW ENGLAND JOURNAL OF MEDICINE"}],"container-title":["Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/science.169.3941.203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T14:36:03Z","timestamp":1704983763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/science.169.3941.203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1970,7,10]]},"references-count":14,"journal-issue":{"issue":"3941","published-print":{"date-parts":[[1970,7,10]]}},"alternative-id":["10.1126\/science.169.3941.203"],"URL":"https:\/\/doi.org\/10.1126\/science.169.3941.203","relation":{},"ISSN":["0036-8075","1095-9203"],"issn-type":[{"value":"0036-8075","type":"print"},{"value":"1095-9203","type":"electronic"}],"subject":[],"published":{"date-parts":[[1970,7,10]]}}}